These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19081564)

  • 21. Oral misoprostol for preventing postpartum haemorrhage in home births in rural Bangladesh: how effective is it?
    Hashima-E-Nasreen ; Nahar S; Al Mamun M; Afsana K; Byass P
    Glob Health Action; 2011; 4():. PubMed ID: 21845143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Misoprostol to prevent and treat postpartum haemorrhage: a systematic review and meta-analysis of maternal deaths and dose-related effects.
    Hofmeyr GJ; Gülmezoglu AM; Novikova N; Linder V; Ferreira S; Piaggio G
    Bull World Health Organ; 2009 Sep; 87(9):666-77. PubMed ID: 19784446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling maternal mortality in Bangladesh: the role of misoprostol in postpartum hemorrhage prevention.
    Prata N; Bell S; Quaiyum MA
    BMC Pregnancy Childbirth; 2014 Feb; 14():78. PubMed ID: 24555848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral misoprostol for prevention of postpartum hemorrhage by paramedical workers in India.
    Chandhiok N; Dhillon BS; Datey S; Mathur A; Saxena NC
    Int J Gynaecol Obstet; 2006 Feb; 92(2):170-5. PubMed ID: 16371228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postpartum hemorrhage.
    Lee N
    Am J Nurs; 2007 Apr; 107(4):15. PubMed ID: 17413716
    [No Abstract]   [Full Text] [Related]  

  • 26. Scaling up high-impact interventions: how is it done?
    Smith JM; de Graft-Johnson J; Zyaee P; Ricca J; Fullerton J
    Int J Gynaecol Obstet; 2015 Jun; 130 Suppl 2():S4-10. PubMed ID: 26115856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility and acceptability of clean birth kits containing misoprostol for self-administration to prevent postpartum hemorrhage in rural Papua New Guinea.
    Vallely LM; Homiehombo P; Walep E; Moses M; Tom M; Kelly-Hanku A; Vallely A; Nataraye E; Ninnes C; Mola GD; Morgan C; Kaldor JM; Wand H; Whittaker A; Homer CS
    Int J Gynaecol Obstet; 2016 Jun; 133(3):301-6. PubMed ID: 26971258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scaling Up Misoprostol to Prevent Postpartum Hemorrhage at Home Births in Mozambique: A Case Study Applying the ExpandNet/WHO Framework.
    Hobday K; Hulme J; Prata N; Wate PZ; Belton S; Homer C
    Glob Health Sci Pract; 2019 Mar; 7(1):66-86. PubMed ID: 30926738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Community-based interventions to reduce maternal mortality.
    Ahmed Y; Mwaba P; Grange J; Green C; Zumla A
    Lancet; 2010 Feb; 375(9713):457-8; author reply 458-9. PubMed ID: 20152533
    [No Abstract]   [Full Text] [Related]  

  • 30. Is attendant at delivery associated with the use of interventions to prevent postpartum hemorrhage at home births? The case of Bangladesh.
    Prata N; Bell S; Holston M; Quaiyum MA
    BMC Pregnancy Childbirth; 2014 Jan; 14():24. PubMed ID: 24428902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knowledge, acceptability, and use of misoprostol for preventing postpartum hemorrhage following home births in rural Ethiopia.
    Gebre B; Taddese Z; Deribe K; Legesse T; Omar M; Biadgilign S
    Int J Gynaecol Obstet; 2016 Jul; 134(1):79-82. PubMed ID: 27090217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Training traditional birth attendants to use misoprostol and an absorbent delivery mat in home births.
    Prata N; Quaiyum MA; Passano P; Bell S; Bohl DD; Hossain S; Azmi AJ; Begum M
    Soc Sci Med; 2012 Dec; 75(11):2021-7. PubMed ID: 22921713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors associated with acute postpartum hemorrhage in low-risk women delivering in rural India.
    Geller SE; Goudar SS; Adams MG; Naik VA; Patel A; Bellad MB; Patted SS; Edlavitch SA; Moss N; Kodkany BS; Derman RJ
    Int J Gynaecol Obstet; 2008 Apr; 101(1):94-9. PubMed ID: 18291401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Commentary on 'Community-based distribution of misoprostol: is this the way forward?'.
    Mathai M
    BJOG; 2014 Feb; 121(3):325-6. PubMed ID: 24575434
    [No Abstract]   [Full Text] [Related]  

  • 35. Misoprostol and active management of the third stage of labor.
    Prata N; Hamza S; Gypson R; Nada K; Vahidnia F; Potts M
    Int J Gynaecol Obstet; 2006 Aug; 94(2):149-55. PubMed ID: 16828767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Avoidable maternal deaths: three ways to help now.
    Prata N; Graff M; Graves A; Potts M
    Glob Public Health; 2009; 4(6):575-87. PubMed ID: 19326279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Home use of misoprostol to prevent PPH. Editor's Comment.
    Fortney JA
    Int J Gynaecol Obstet; 2010 Mar; 108(3):268. PubMed ID: 20053401
    [No Abstract]   [Full Text] [Related]  

  • 38. Introducing misoprostol for the management of postpartum hemorrhage in Zimbabwe: final report on operational research.
    Zvandasara P; Chipato T; Mawere E; Rivelt K; McNally T
    Cent Afr J Med; 2015; 61(9-12):76-83. PubMed ID: 29144067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Misoprostol use in the community to reduce maternal death.
    Gülmezoglu AM; Mathai M; Souza JP; d'Arcangues C; Mbizvo M
    Lancet; 2010 Sep; 376(9745):955; author reply 955-6. PubMed ID: 20851254
    [No Abstract]   [Full Text] [Related]  

  • 40. Misoprostol: preventing postpartum haemorrhage.
    Walder J
    Mod Midwife; 1997 Sep; 7(9):23-7. PubMed ID: 9370621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.